Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 30, 2022 - Issue 7-8
Submit an article Journal homepage
77
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Two Cases of Extremely High-IL-6 Pan-uveitis with Subretinal Exudation and Cell Migration

Mizuki TagamiDepartment of Ophthalmology and Visual Sciences, Graduate School of Medicine, Osaka City University, Osaka, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8771-7252View further author information
, MD, PhDORCID Icon,
Norihiko MisawaDepartment of Ophthalmology and Visual Sciences, Graduate School of Medicine, Osaka City University, Osaka, JapanView further author information
, MD,
Atsushi SakaiDepartment of Ophthalmology and Visual Sciences, Graduate School of Medicine, Osaka City University, Osaka, JapanView further author information
, MD &
Shigeru HondaDepartment of Ophthalmology and Visual Sciences, Graduate School of Medicine, Osaka City University, Osaka, JapanView further author information
, MD, PhD
Pages 1577-1581 | Received 01 Dec 2020, Accepted 18 Mar 2021, Published online: 12 May 2021

References

  • Goto H, Mochizuki M, Yamaki K, et al. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007;51(1):41–44. doi:10.1007/s10384-006-0383-4. [published Online First: 2007/02/14].
  • Wakefield D, Chang JH. Epidemiology of uveitis. Int Ophthalmol Clin. 2005;45(2):1–13. doi:10.1097/01.iio.0000155938.83083.94. [published Online First: 2005/03/26].
  • Tsubota K, Usui Y, Goto H. Identification of prognostic markers in patients with primary vitreoretinal lymphoma by clustering analysis using clinical data. J Clin Med. 2020;9(7): doi:10.3390/jcm9072298. [published Online First: 2020/07/24].
  • Kuo DE, Wei MM, Knickelbein JE, et al. Logistic regression classification of primary vitreoretinal lymphoma versus uveitis by interleukin 6 and interleukin 10 levels. Ophthalmology. 2020;127(7):956–962. doi:10.1016/j.ophtha.2020.01.042. [published Online First: 2020/03/22].
  • Pochat-Cotilloux C, Bienvenu J, Nguyen AM, et al. Use of a threshold of INTERLEUKIN-10 AND IL-10/IL-6 RATIO IN ocular samples for the screening of vitreoretinal lymphoma. Retina. 2018;38(4):773–781. doi:10.1097/iae.0000000000001922. [published Online First: 2017/11/15].
  • Kang S, Tanaka T, Inoue H, et al. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. Proc Natl Acad Sci U S A. 2020;117(36):22351–22356. doi:10.1073/pnas.2010229117. [published Online First: 2020/08/23].
  • Choy EH, De Benedetti F, Takeuchi T, et al. Translating IL-6 biology into effective treatments. Nat Rev Rheumatol. 2020;16(6):335–345. doi:10.1038/s41584-020-0419-z. [published Online First: 2020/04/25].
  • Mesquida M, Molins B, Llorenç V, et al. Targeting interleukin-6 in autoimmune uveitis. Autoimmun Rev. 2017;16(10):1079–1089. doi:10.1016/j.autrev.2017.08.002. [published Online First: 2017/08/06].
  • Nakano S, Tomaru Y, Kubota T, et al. Evaluation of a multiplex strip PCR test for infectious uveitis: a prospective multicenter study. Am J Ophthalmol. 2020;213:252–259. doi:10.1016/j.ajo.2019.10.031. [published Online First: 2019/12/01].
  • Sugita S, Takase H, Sugamoto Y, et al. Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid. Jpn J Ophthalmol. 2009;53(3):209–214. doi:10.1007/s10384-009-0662-y. [published Online First: 2009/06/02].
  • Murray PI, Hoekzema R, van Haren MA, et al. Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Visual Sci. 1990 [published Online First: 1990/05/01];31(5):917–920.
  • Matas J, Llorenç V, Fonollosa A, et al. Systemic regulatory T cells and IL-6 as prognostic factors for anatomical improvement of uveitic macular edema. Front Immunol. 2020;11:579005. doi:10.3389/fimmu.2020.579005. [published Online First: 2020/10/27].
  • Noma H, Funatsu H, Mimura T, et al. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology. 2009;116(1):87–93. doi:10.1016/j.ophtha.2008.09.034. [published Online First: 2009/01/03].
  • van Kooij B, Rothova A, Rijkers GT, et al. Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema. Am J Ophthalmol. 2006;142(1):192–194. doi:10.1016/j.ajo.2006.02.052. [published Online First: 2006/07/04].
  • Cunningham ET, Adán A, Nguyen QD, et al. Tocilizumab for the treatment of ocular inflammatory disease. Ocul Immunol Inflamm. 2021;29(1):2–5. doi:10.1080/09273948.2020.1859257. [published Online First: 2021/01/13].
  • Silpa-Archa S, Oray M, Preble JM, et al. Outcome of tocilizumab treatment in refractory ocular inflammatory diseases. Acta Ophthalmol. 2016;94(6):e400–6. doi:10.1111/aos.13015. [published Online First: 2016/03/25].
  • Papo M, Bielefeld P, Vallet H, et al. Tocilizumab in severe and refractory non-infectious uveitis. Clin Exp Rheumatol. 2014;32(4Suppl 84):S75–9. [published Online First: 2014/10/01].
  • Disease ITftRotICfBs, Davatchi F, Assaad-Khalil S, et al. The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereology. 2014;28(3):338–347. doi:10.1111/jdv.12107.
  • Henry CR, Shah M, Barakat MR, et al. Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA). Br J Ophthalmol. 2021. doi:10.1136/bjophthalmol-2020-318019. [published Online First: 2021/02/07].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.